Join
Live feed
·
INSIDERFilingvia Quantisnow
Eyegate Pharmaceuticals, Inc. logo

SEC Form 4: Sarah Romano disposed of $1,190 worth of Common Stock (218 units at $5.46), decreasing direct ownership by 0.90% to 24,113 units

ByQuantisnow·Wall Street's wire, on your screen.
EYEG· Eyegate Pharmaceuticals, Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EYEG (Eyegate Pharmaceuticals, Inc.) and more on Quantisnow.